Press Releases
Kforce Reports Third Quarter Results
-
Record Revenue of
$289.0 Million -
Earnings Per Share of
$0.22 - Sequential Flex Revenue Increase of 5.8%
-
In 2011, Kforce Repurchased 13.1% of Shares Outstanding at
December 31, 2010 -
Repurchase Authorization Increased by
$75.0 Million
"We are very pleased with our third quarter results, particularly our record quarterly revenues of
-
Flex revenue per billing day of
$4.3 million in Q3 '11 increased 5.8% over Q2 '11 and increased 11.3% over Q3 '10.
-
Sequential percentage increases in Flex revenue by segment were 8.8% for Government Solutions, 6.9% for Tech, 6.1% for HLS and 1.1% for FA.
-
Search revenue of
$11.9 million in Q3 '11 decreased 2.6% from$12.2 million in Q2 '11 and increased 12.4% from$10.6 million in Q3 '10.
-
Total Tech revenue of
$165.5 million and total Tech Flex revenue of$160.3 million surpassed the prior records of$154.5 million and$150.0 million , respectively, which were achieved in Q2 '11.
Financial highlights for the third quarter include:
-
Flex gross profit increased 50 basis points to 28.9% in Q3 '11 from 28.4% in Q2 '11 and decreased 40 basis points from 29.3% in Q3 '10.
-
Selling, general and administrative expenses as a percentage of revenue decreased 30 basis points to 26.0% in Q3 '11 from 26.3% in Q2 '11 and decreased 70 basis points from 26.7% in Q3 '10.
-
Adjusted EBITDA for Q3 '11 was
$20.1 million , an increase of 16.3% from$17.3 million in Q2 '11 and an increase of 27.8% from$15.7 million in Q3 '10.
-
Bank debt at the end of Q3 '11 was
$59.4 million , reflecting an increase of$40.5 million from$18.9 million at the end of Q2 '11. This increase was primarily related to the repurchase of 4.6 million shares of common stock during the third quarter.
On
This call is being webcast by Shareholder.com and can be accessed at
About
The
About
KGS provides innovative technology, financial management, data architecture and continuous process improvement and finance and accounting solutions primarily to federal government clients. KGS, with approximately 600 professionals currently on assignment, has been partnering with our clients since 1970 to successfully solve their challenges. KGS' in-depth operational knowledge and understanding of Federal Agencies, the
Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Factors that could cause actual results to differ materially include the following: business conditions and growth in the staffing industry and general economy; competitive factors, risks due to shifts in the market demand, including, without limitation, shifts in demand for our Technology, Finance and Accounting, Health and Life Sciences and Government Solutions segments, as well as the market for search and flexible staffing assignments; changes in the service mix; ability of the Firm to complete acquisitions; and the risk factors listed from time
to time in the Firm's reports filed with the
|
|||
Summary of Operations | |||
(In Thousands, Except Per Share Amounts) | |||
(Unaudited) | |||
Three Months Ended | |||
Sept. 30, 2011 |
Jun. 30, 2011 |
Sept. 30, 2010 |
|
Revenue by function: | |||
Technology | $ 165,476 | $ 154,534 | $ 141,930 |
Finance & accounting | 54,297 | 54,774 | 50,170 |
Health & life sciences | 45,337 | 42,735 | 41,229 |
Government solutions | 23,881 | 21,946 | 26,190 |
Total revenue | 288,991 | 273,989 | 259,519 |
Revenue by time: | |||
Flex | 277,123 | 261,808 | 248,960 |
Search | 11,868 | 12,181 | 10,559 |
Total revenue | 288,991 | 273,989 | 259,519 |
Costs of services | 196,953 | 187,341 | 176,054 |
Gross profit | 92,038 | 86,648 | 83,465 |
GP % | 31.8% | 31.6% | 32.2% |
Flex GP % | 28.9% | 28.4% | 29.3% |
Selling, general & administrative expenses | 75,134 | 72,163 | 69,321 |
Depreciation & amortization | 3,072 | 3,211 | 3,236 |
Income from operations | 13,832 | 11,274 | 10,908 |
Other expense, net | 301 | 335 | 387 |
Income before income taxes | 13,531 | 10,939 | 10,521 |
Income tax expense | 5,085 | 4,154 | 4,077 |
Net income | $ 8,446 | $ 6,785 | $ 6,444 |
Earnings per share - diluted | $ 0.22 | $ 0.17 | $ 0.16 |
Adjusted EBITDA per share | $ 0.52 | $ 0.43 | $ 0.39 |
Shares outstanding - diluted | 38,228 | 40,465 | 40,384 |
Adjusted EBITDA | $ 20,084 | $ 17,276 | $ 15,710 |
Other information: | |||
Capital expenditures | $ 2,113 | $ 1,400 | $ 3,345 |
Equity-based compensation expense, net | $ 1,931 | $ 1,762 | $ 1,171 |
Working capital | $ 100,766 | $ 71,969 | $ 76,762 |
Selected balance sheet information: | |||
Cash and cash equivalents | $ 1,025 | $ 685 | $ 454 |
Accounts receivable, less allowances | $ 186,843 | $ 166,724 | $ 154,160 |
Total assets | $ 420,397 | $ 404,923 | $ 392,949 |
Bank debt | $ 59,384 | $ 18,934 | $ 20,000 |
Total liabilities | $ 193,747 | $ 147,061 | $ 145,286 |
Total stockholders' equity | $ 226,650 | $ 257,862 | $ 247,663 |
Billing days | 64 | 64 | 64 |
|
|||
Key Statistics | |||
(Unaudited) | |||
Q3 2011 | Q2 2011 | Q3 2010 | |
Total Firm | |||
Flex revenue (000's) | $ 277,123 | $ 261,808 | $ 248,960 |
Revenue per billing day (000's) | $ 4,330 | $ 4,091 | $ 3,890 |
Sequential flex revenue change | 5.8% | 3.8% | 5.4% |
Hours (000's) | 4,486 | 4,318 | 4,019 |
Flex GP % | 28.9% | 28.4% | 29.3% |
Search revenue (000's) | $ 11,868 | $ 12,181 | $ 10,559 |
Placements | 884 | 933 | 824 |
Average fee | $ 13,424 | $ 13,058 | $ 12,819 |
Billing days | 64 | 64 | 64 |
Technology | |||
Flex revenue (000's) | $ 160,285 | $ 149,997 | $ 137,326 |
Revenue per billing day (000's) | $ 2,504 | $ 2,344 | $ 2,146 |
Sequential flex revenue change | 6.9% | 7.6% | 5.7% |
Hours (000's) | 2,520 | 2,403 | 2,186 |
Flex GP % | 27.7% | 27.1% | 28.0% |
Search revenue (000's) | $ 5,191 | $ 4,537 | $ 4,604 |
Placements | 354 | 313 | 311 |
Average fee | $ 14,682 | $ 14,488 | $ 14,822 |
Finance & Accounting | |||
Flex revenue (000's) | $ 48,046 | $ 47,522 | $ 44,437 |
Revenue per billing day (000's) | $ 751 | $ 743 | $ 694 |
Sequential flex revenue change | 1.1% | -0.7% | 16.5% |
Hours (000's) | 1,406 | 1,393 | 1,340 |
Flex GP % | 30.1% | 29.5% | 30.9% |
Search revenue (000's) | $ 6,251 | $ 7,252 | $ 5,733 |
Placements | 499 | 594 | 497 |
Average fee | $ 12,516 | $ 12,218 | $ 11,533 |
Health & Life Sciences | |||
Flex revenue (000's) | $ 44,911 | $ 42,343 | $ 41,007 |
Revenue per billing day (000's) | $ 702 | $ 662 | $ 641 |
Sequential flex revenue change | 6.1% | 1.6% | -0.1% |
Hours (000's) | 560 | 522 | 493 |
Flex GP % | 30.2% | 30.4% | 28.8% |
Search revenue (000's) | $ 426 | $ 392 | $ 222 |
Placements | 31 | 26 | 16 |
Average fee | $ 13,695 | $ 15,004 | $ 13,876 |
Government Solutions | |||
Flex revenue (000's) | $ 23,881 | $ 21,946 | $ 26,190 |
Revenue per billing day (000's) | $ 373 | $ 343 | $ 409 |
Sequential flex revenue change | 8.8% | -6.0% | -3.3% |
Flex GP % | 32.3% | 31.7% | 34.3% |
|
|||
Key Statistics - Health & Life Sciences | |||
(Unaudited) | |||
Q3 2011 | Q2 2011 | Q3 2010 | |
Clinical Research | |||
Flex revenue (000's) | $ 27,703 | $ 25,742 | $ 26,331 |
Revenue per billing day (000's) | $ 433 | $ 402 | $ 412 |
Sequential flex revenue change | 7.6% | 0.0% | -4.2% |
Hours (000's) | 297 | 270 | 282 |
Flex GP % | 26.2% | 26.7% | 26.6% |
Search revenue (000's) | $ 264 | $ 224 | $ 92 |
Placements | 10 | 10 | 5 |
Average fee | $ 26,393 | $ 22,433 | $ 18,333 |
Health Information Management | |||
Flex revenue (000's) | $ 17,208 | $ 16,601 | $ 14,676 |
Revenue per billing day (000's) | $ 269 | $ 260 | $ 229 |
Sequential flex revenue change | 3.7% | 4.2% | 8.1% |
Hours (000's) | 263 | 252 | 211 |
Flex GP % | 36.6% | 36.2% | 32.8% |
Search revenue (000's) | $ 162 | $ 168 | $ 130 |
Placements | 21 | 16 | 11 |
Average fee | $ 7,678 | $ 10,408 | $ 11,850 |
|
||||||
Selected Financial Information and Reconciliations | ||||||
(In Thousands, Except Per Share Amounts) | ||||||
(Unaudited) | ||||||
Quarterly Adjusted EBITDA | ||||||
Three Months Ended | ||||||
Sept. 30, 2011 |
Jun. 30, 2011 |
Sept. 30, 2010 |
||||
$ | Per share | $ | Per share | $ | Per share | |
Net income | $ 8,446 | $ 0.22 | $ 6,785 | $ 0.17 | $ 6,444 | $ 0.16 |
Depreciation & amortization | 3,072 | 0.08 | 3,211 | 0.08 | 3,236 | 0.08 |
Amortization of restricted stock & PARS | 3,088 | 0.08 | 2,837 | 0.07 | 1,631 | 0.04 |
Interest expense and other | 393 | 0.01 | 289 | 0.01 | 322 | 0.01 |
Income tax expense | 5,085 | 0.13 | 4,154 | 0.10 | 4,077 | 0.10 |
Adjusted EBITDA | $ 20,084 | $ 0.52 | $ 17,276 | $ 0.43 | $ 15,710 | $ 0.39 |
Weighted average shares outstanding - diluted | 38,228 | 40,465 | 40,384 | |||
Adjusted EBITDA, a non-GAAP financial measure, is defined as net income before non-cash impairment charges, interest, income taxes, depreciation and amortization and amortization of stock-based compensation expense. Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. | ||||||
Quarterly Net Income before Equity-Based Compensation Expense | ||||||
Three Months Ended | ||||||
Sept. 30, 2011 |
Jun. 30, 2011 |
Sept. 30, 2010 |
||||
$ | Per share | $ | Per share | $ | Per share | |
Net income | $ 8,446 | $ 0.22 | $ 6,785 | $ 0.17 | $ 6,444 | $ 0.16 |
Equity-based compensation expense, net: | ||||||
Alternative LTI expense | 5 | 0.00 | 4 | 0.00 | 281 | 0.01 |
Amortization of restricted stock & PARS | 3,088 | 0.08 | 2,837 | 0.07 | 1,631 | 0.04 |
Income tax benefit | (1,162) | (0.03) | (1,079) | (0.03) | (741) | (0.02) |
Equity-based compensation expense, net | 1,931 | 0.05 | 1,762 | 0.04 | 1,171 | 0.03 |
Net income before equity-based compensation expense | $ 10,377 | $ 0.27 | $ 8,547 | $ 0.21 | $ 7,615 | $ 0.19 |
Weighted average shares outstanding - diluted | 38,228 | 40,465 | 40,384 | |||
"Net Income before Equity-Based Compensation Expense," a non-GAAP financial measure, is defined as net income before compensation expense incurred in conjunction with share-based payment awards and alternative long-term incentive awards. |
||||||
Adjusted EBITDA and Net Income before Equity-Based Compensation Expense are key measures used by management to evaluate its operations and to provide useful information to investors. These measures should not be considered in isolation or as an alternative to net income, cash flows data or other financial statement information presented in the consolidated financial statements as indicators of financial performance or liquidity. These measurements are not determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations. The measures as presented may not be comparable to similarly titled measures of other companies. |
CONTACT:Source:Michael R. Blackman Chief Corporate Development Officer (813) 552-2927
News Provided by Acquire Media